Aptevo Therapeutics (APVO) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-87.8
-61.12
-34.43
-7.75

Details

Expected EPS
-83.2
Actual EPS
-8.4
Surprise EPS
74.8
Surprise Percent
+89.9%

Description

Aptevo Therapeutics (APVO) has reported earnings of -8.4 per share for Q3 2025.

0 Comments

Share your thoughts